Consistently, delivering the humanized anti-BAG3 antibody BAG3-H2L4 abrogates this binding and leads to a prominent growth reduction in the Mia PaCa-2 pancreatic cancer cell xenograft model [196]. This evidence concerns the gene BAG3 and familial pancreatic carcinoma.